Chronic Obstructive Pulmonary Disease-Derived Circulating Cells Release IL-18 and IL-33 under Ultrafine Particulate Matter Exposure in a Caspase-1/8-Independent Manner-Reference-Cited by-同舟云学术

Chronic Obstructive Pulmonary Disease-Derived Circulating Cells Release IL-18 and IL-33 under Ultrafine Particulate Matter Exposure in a Caspase-1/8-Independent Manner

Published:2017-10-26 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

De Falco Gianluigi,Colarusso Chiara,Terlizzi Michela,Popolo Ada,Pecoraro Michela,Commodo Mario,Minutolo Patrizia,Sirignano Mariano,D’Anna Andrea,Aquino Rita P.,Pinto Aldo,Molino Antonio,Sorrentino Rosalinda

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference27 articles.

1. Role of the inflammasome in chronic obstructive pulmonary disease (COPD);Colarusso;Oncotarget,2017

2. Biologic therapy in chronic obstructive pulmonary disease;Tripple;Immunol Allergy Clin North Am,2017

3. COPD immunopathology;Caramori;Semin Immunopathol,2016

4. Lung cancer in chronic obstructive pulmonary disease;Raviv;Am J Respir Crit Care Med,2011

5. Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection;Kearley;Immunity,2015

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of NLRP3 inflammasome activation in patients with chronic obstructive pulmonary disease before and after lung transplantation;Immunologic Research;2024-05-29

2. Fine particulate matter aggravates smoking induced lung injury via NLRP3/caspase-1 pathway in COPD;Journal of Inflammation;2024-04-24

3. To Explore the Relationship between Pyroptosis and the Pathogenesis of Phlegm and Blood Stasis in Acute Exacerbation of COPD;Advances in Clinical Medicine;2024

4. Absent in melanoma 2 (AIM2) positive profile identifies a poor prognosis of lung adenocarcinoma patients;International Immunopharmacology;2023-11

5. Epithelial alarmins: a new target to treat chronic respiratory diseases;Expert Review of Respiratory Medicine;2023-09-02